Subjective and objective assessment of efficacy and tolerability of mirabegron, a ß(3)-adrenoceptor agonist, in clinical use

Sugino Y1, Matsuoka T1, Kobayashi T1, Terada N1, Yamasaki T1, Matsui Y1, Okubo K1, Kamba T1, Ogawa O1, Yoshimura K1

Abstract Category

Epidemiology & Outcomes Research

Abstract 831
Read By Title
Scientific Non Discussion Abstract Session 35
Overactive Bladder Outcomes Research Methods Questionnaire Voiding Diary
1. Department of Urology, Kyoto University
Links

Abstract

27/04/2024 02:01:30